Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 81.65 INR
Change Today 0.00 / 0.00%
Volume 0.0
ELDP On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

elder pharmaceuticals ltd (ELDP) Snapshot

Open
80.40
Previous Close
81.75
Day High
83.15
Day Low
79.60
52 Week High
06/11/14 - 234.10
52 Week Low
03/27/15 - 79.60
Market Cap
1.7B
Average Volume 10 Days
21.9K
EPS TTM
-3.18
Shares Outstanding
20.5M
EX-Date
09/17/12
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ELDER PHARMACEUTICALS LTD (ELDP)

Related News

No related news articles were found.

elder pharmaceuticals ltd (ELDP) Related Businessweek News

No Related Businessweek News Found

elder pharmaceuticals ltd (ELDP) Details

Elder Pharmaceuticals Limited manufactures and markets prescription pharmaceutical brands, and surgical and medical devices in India and internationally. The company offers various products in the therapeutic areas of nutraceuticals, anti-infectives, pain management, and life-style disorders. It also provides products in the categories of anti-biotics, CNS, CVS, GI, gynae, antiinflamattory, haematinics, immunomodulators, multivitamin multinutrients, eye-ear drops, respiratory, vascular system, pre pro biotics, woundcare, antiarthritic, musculoskeletal system, paediatric formulations, immune system, anti fungals, and genito urinary system. The company provides its products in various dosage forms, such as tablets, capsules, syrups, injectables, oral rinse, skin creams, and ointments. Elder Pharmaceuticals Limited was incorporated in 1983 and is based in Mumbai, India.

Founded in 1983

elder pharmaceuticals ltd (ELDP) Top Compensated Officers

Chief Executive Officer, Managing Director, W...
Total Annual Compensation: 7.9M
Compensation as of Fiscal Year 2014.

elder pharmaceuticals ltd (ELDP) Key Developments

Elder Pharmaceuticals Limited Reports Unaudited Standalone and Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015

Elder Pharmaceuticals Limited reported unaudited standalone and consolidated earnings results for the third quarter and nine months ended March 31, 2015. For the quarter, on standalone basis, the company reported net sales/income from operations (net of excise duty) of INR 239.940 million against INR 1,010.052 million for the same period previous year. Loss from operations before other income, finance costs & exceptional items was INR 307.227 million against INR 207.843 million for the same period of previous year. Loss from ordinary activities before tax was INR 512.060 million against INR 752.822 million for the same period of previous year. Net loss was INR 512.060 million or INR 24.93 per basic share compared to INR 752.822 million or INR 36.66 per basic share for the same period of previous year. For the nine months, on standalone basis, the company reported net sales/income from operations (net of excise duty) of INR 1,428.336 million against INR 3,906.983 million for the same period previous year. Loss from operations before other income, finance costs & exceptional items was INR 1,037.672 million against profit from operations before other income, finance costs & exceptional items of INR 316.343 million for the same period of previous year. Loss from ordinary activities before tax was INR 1,711.193 million against INR 918.504 million for the same period of previous year. Net loss was INR 1,711.193 million or INR 83.32 per basic share compared to INR 918.504 million or INR 44.72 per basic share for the same period of previous year. For the quarter, on consolidated basis, the company reported net sales/income from operations (net of excise duty) of INR 1,512.951 million against INR 2,274.066 million for the same period previous year. Loss from operations before other income, finance costs & exceptional items was INR 220.122 million against INR 180.719 million for the same period of previous year. Loss from ordinary activities before tax was INR 431.420 million against INR 719.109 million for the same period of previous year. Net loss was INR 460.224 million or INR 22.41 per basic share compared to INR 736.322 million or INR 35.85 per basic share for the same period of previous year. For the nine months, on consolidated basis, the company reported net sales/income from operations (net of excise duty) of INR 5,084.960 million against INR 8,833.043 million for the same period previous year. Loss from operations before other income, finance costs & exceptional items was INR 983.616 million against profit from operations before other income, finance costs & exceptional items of INR 391.517 million for the same period of previous year. Loss from ordinary activities before tax was INR 1,726.235 million against INR 905.175 million for the same period of previous year. Net loss was INR 1,761.531 million or INR 85.77 per basic share compared to INR 938.230 million or INR 45.69 per basic share for the same period of previous year.

Elder Pharmaceuticals, Board Meeting, May 05, 2015

Elder Pharmaceuticals, Board Meeting, May 05, 2015. Agenda: To consider un-audited financial results of the company for the quarter ended March 31, 2015; to consider any other matter with permission of the Chair.

Elder Pharmaceuticals to Report Q4, 2015 Results on May 05, 2015

Elder Pharmaceuticals announced that they will report Q4, 2015 results on May 05, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ELDP:IN 81.65 INR 0.00

ELDP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $49.03 USD -0.31
Cadila Healthcare Ltd 1,752 INR 0.00
Cipla Ltd/India 673.90 INR 0.00
GlaxoSmithKline PLC 1,465 GBp +14.00
View Industry Companies
 

Industry Analysis

ELDP

Industry Average

Valuation ELDP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book 0.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELDER PHARMACEUTICALS LTD, please visit www.elderindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.